Delivery Order SPE2DB22D3301-SPE2DB24FZ2LW
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,831.49 firm fixed price delivery order is for the supply of 40,000 units of the medication PROCRIT. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,427.82 firm-fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT, with a completion date of September 13, 2024. This award is not set aside for a specific business type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,837.39, is for the procurement of 10,000 units of PROCRIT 10,000 units/mL vials. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The award, valued at $3,922.08, is a firm fixed price delivery order for the supply of PROCRIT 20,000 units/ml vials. The contract has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,784.99 delivery order is for the supply of 10,000 units/ml of the drug Procrit. This award does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,628.50, is a delivery order for the procurement of 10,000 units of Procrit (10,000 units/mL vial) for the DLA's medical supply requirements. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in the distribution of a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,542.20 fixed-price delivery order is for the procurement of 40,000 units of the drug Procrit with a strength of 40,000 units/mL. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROCRIT 40,000 UNITS/ML VIALML to the Defense Logistics Agency (DLA). The $5,947.54 firm fixed-price delivery order has a completion date of July 15, 2024. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. Under this single-award IDC, Amerisourcebergen provides a...
This contract award is for Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 10,000 units/ml of the medication Procrit to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $8,083.06, has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by...